Patients with cancer have elevated cardiovascular risks compared to those without cancer.
As cancer incidence increases and cancer-related mortality decreases, cardiovascular …

Cancer therapy can result in acute cardiac events, such as coronary artery spasm, acute
myocardial infarction, thromboembolism, myocarditis, bradycardia, tachyarrhythmias, atrio …

Immune checkpoint inhibitors (ICIs) are increasingly used but are associated with
cardiotoxicity [1–3]. The cardiovascular needs of ICI users were addressed by the European …

Background: Routinely collected health data are increasingly used in clinical research. No
study has systematically reviewed the temporal trends in the number of publications and …

Background Over the past decade, immune checkpoint inhibitors (ICIs) have significantly
transformed cancer treatment. However, ICIs inevitably may cause a spectrum of immune …

Background Immune checkpoint inhibitor (ICI) has become a major breakthrough in the field
of tumor therapy, leading to improved survival. This study evaluated the clinical and …

Background Immune checkpoint inhibitors (ICI) are increasingly used in the first‐line
treatment of malignant tumors. There is increasing recognition of their cardiotoxicity and, in …

Investigational New Drugs that the nivolumab-induced myocarditis is hypersensitivity
myocarditis a type of myocarditis first described by the authors of this letter [6] …

The most frequent cause of cardiac failure globally is ischemic heart disease, with
chemothera-py-related cardiovascular side effects emerging as the second most frequent …

Background: Routinely collected health data are increasingly used for clinical or
epidemiological research. However, no study has systematically reviewed the temporal …